Clinical Trial Results

Condition: Depression Location: District of Columbia 25 trials found

E-Mindfulness Approaches for Living After Breast Cancer

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic

NAINTERVENTIONAL Washington D.C., District of Columbia

Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method

NAINTERVENTIONAL Washington D.C., District of Columbia

Mindful Self-Compassion for Anxiety Disorders and Depression

NAINTERVENTIONAL Washington D.C., District of Columbia

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

N/AOBSERVATIONAL Bethesda, Maryland

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

PHASE1INTERVENTIONAL Bethesda, Maryland

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

N/AOBSERVATIONAL Bethesda, Maryland

PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)

PHASE1INTERVENTIONAL Bethesda, Maryland

Long-term Observation of Participants With Mood Disorders

N/AOBSERVATIONAL Bethesda, Maryland

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

NAINTERVENTIONAL Eglin Air Force Base, Florida +4 more

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

N/AOBSERVATIONAL Bethesda, Maryland

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

PHASE1INTERVENTIONAL Bethesda, Maryland

Natural History of Depression, Bipolar Disorder and Suicide Risk

N/AOBSERVATIONAL Bethesda, Maryland

Neurobiology of Suicide

PHASE2INTERVENTIONAL Bethesda, Maryland

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

PHASE1INTERVENTIONAL Bethesda, Maryland

Characterization and Treatment of Adolescent Depression

N/AOBSERVATIONAL Los Angeles, California +2 more

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

PHASE2INTERVENTIONAL Bethesda, Maryland

Clinical Validation of a Predictive Test for Postpartum Depression

N/AOBSERVATIONAL Charlottesville, Virginia +1 more

rTMS for Military TBI-related Depression

NAINTERVENTIONAL Palo Alto, California +2 more

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

PHASE2INTERVENTIONAL Tucson, Arizona +4 more

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

ALTO-100 in Bipolar Disorder With Depression (BD-D)

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

Evaluating Conversational Artificial Intelligence for Depression Management

NAINTERVENTIONAL Fairfax, Virginia